中国第三次死因抽样调查（2004--2005）卵巢癌死亡情况分析  

Ovary cancer mortality in China 2004 - 2005： results from the Third National Retrospective Sampling Survey of Death Causes

作　　者：张思维[1] 陈万青[1] 魏文强[2] 李光琳[3] 李霓[1] 李媛秋[1] 

机构地区：[1]中国医学科学院肿瘤医院肿瘤研究所全国肿瘤防治研究办公室,北京100021 [2]中国医学科学院肿瘤医院,肿瘤研究所流行病室,北京100021 [3]中国医学科学院肿瘤医院卫生部疾病预防控制局,北京100021

出　　处：《中华预防医学杂志》2010年第5期418-422,共5页Chinese Journal of Preventive Medicine

基　　金：卫生部、科技部全国第三次死因回顾抽样调查项目

摘　　要：目的利用全国第3次死因回顾抽样调查的结果，分析我国卵巢癌死亡的分布特点及流行趋势。方法采用2004--2005年全国第3次死因回顾抽样调查158个样本点的资料，全国样本地区调查女性人口69690241人年（其中城市23598822人年，农村46091419人年）。按照统一标准划分东、中、西部地区和城市、农村地区，分别计算粗死亡率、年龄别死亡率、标化死亡率、死冈构成，并与1990--1992年全国第2次死因回顾抽样调查资料和世界部分国家的卵巢癌死亡率资料比较。结果2004--2005年女性卵巢癌粗死亡率1．45／10万（1008／69690241），在女性恶性肿瘤死凶顺位中排第12位，占女性全部恶性肿瘤死亡的1．45％（1008／69667），中国人口标化死亡率（简称中标率）为0．97／10万，世界人口标化死亡率为1．26／10万。城市卵巢癌粗死亡率为2．67／10万（630／23598822），中标率为1．62／10万；农村卵巢癌粗死亡率为0．82／10万（378／46091419），中标率为0．59／10万。与1990--1992年调查结果（卵巢癌粗死亡率0．60／10万、中标率0．53／10万和占全部恶性肿瘤死亡的0．75％）比较，卵巢癌粗死亡率上升了141．07％，中标率上升了83．02％，占女性仝部恶性肿瘤死亡的构成比上升了92．92％，死因顺位由第17位上升到第12位，卵巢癌中标率上升幅度农村（118．52％）高于城市（31．71％）。结论卵巢癌不是危害我国居民健康的主要恶性肿瘤，城市卵巢癌死亡率高于农村，近20年来死亡率有较大幅度上升，应充分引起重视。Objective To analyze the distribution characteristics and trend of ovary cancer mortality based on results of the Third National Retrospective Sampling Survey of Death Causes. Methods Data of National Retrospective Sampling Survey for the years of 2004 - 2005 from 158 counties/cities/districts was used for the settings. A total of 69 690 241 person-year for female between 2004 and 2005 including 23 598 822 person-year in urban and 46 091 419 person-year in rural were respectively included in the study. Furthermore, the areas of east, middle, and west were divided into the subsets. And also the areas of urban and rural areas were divided into the subsets. The crude death rate and age-specific death rate and the age-standardized death rate by Chinese population of 1982 （CASR） and by world population of 1960 （WASR） were calculated. The historical comparison with the sampling survey of 1990 - 1992 （ second time） was conducted, and the global comparison with some selected countries was performed. Results The crude death rate for ovary cancer was 1.45/100 000 （ 1008/69 690 241 ） between 2004 and 2005, which was ranked the 12th and accounted for 1.45% （1008/69 667） of all sites of cancers. The CASR was O. 97/100 000 and the WASR was 1.26/100 000. The crude death rate of ovary cancer were 2. 67/100 000 （630/23 598 822） and 0. 82/100 000 （378/46 091 419） in urban and rural areas respectively,with the CASR of 1.62/100 000 and 0. 59/100 000 in urban and rural areas respectively. Compared with the data from the second time （0. 06/100 000 for crude death rate, 0. 53/100 000 for CASR and 0. 75% for proportion）, the crude death rate increased by 141.07% and the CASR increased by 83.02%. The proportion of mortality was increased by 92. 92% , which ranked from the 17th to the 12th. In the urban areas,the CASR of ovary cancer increased by 31.71% （1.23/100 000 vs 1.62/100 000）, while by 118.52% in rural areas （0. 27/100 000 vs 0. 59/100 000） with an increasing trend more remarkable in rural t

关 键 词：卵巢肿瘤 死亡率 抽样研究 流行病学研究 

分 类 号：R737.31[医药卫生—肿瘤]